Market Cap

Zhejiang Shengda Bio-Pharm Co. Ltd Market Capitalization:

CN¥2.47 Billion

CNY as of Jan. 1, 2024

US$347.0 Million

business Zhejiang Shengda Bio-Pharm Co. Ltd Company Profile

Zhejiang Shengda Bio-Pharm Co. Ltd Main Stock Listing

SSE: 603079

Market Capitalization History of Zhejiang Shengda Bio-Pharm Co. Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Zhejiang Shengda Bio-Pharm Co. Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥2.47 B 12.05%
Jan. 1, 2023 CN¥2.20 B -13.53%
Jan. 1, 2022 CN¥2.55 B -26.28%
Jan. 1, 2021 CN¥3.45 B -21.26%
Jan. 1, 2020 CN¥4.39 B 138.67%
Jan. 1, 2019 CN¥1.84 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +313.24%

$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Zhejiang Shengda Bio-Pharm Co. Ltd Categories

China languages Healthcare languages Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Stocks & Indices

Zhejiang Shengda Bio-Pharm Co. Ltd has the following listings and related stock indices.


Stock: SSE: 603079

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.